Publix Pharmacy Fills 100 Millionth Free Prescription

Business Wire | January 02, 2020

Publix Pharmacy Fills 100 Millionth Free Prescription
“We are proud to provide a service that helps our customers afford their medications,” said Publix Vice President of Pharmacy Dain Rusk. “As the cost of health care continues to rise, this program has become even more important to our customers and our communities. Too often, high prescription costs prevent people from taking medication as prescribed. When medications are free or available at a greatly reduced cost, that barrier is lifted, and our customers can get the care they need.” The free medication program began in 2007. It includes 14-day supplies of four oral antibiotics, as well as 90-day supplies of maintenance medications used to treat high blood pressure and diabetes.

Spotlight

There’s a good chance your diet leaves you nutritionally deficient. You may take (or may be thinking about taking) a supplement to make up the deficiency. Dietary supplements are not regulated the same way drugs are regulated, so it’s important to know what you’ll be buying before you head to the store. USP Verified Dietary Supplements are rigorously tested and audited using the four P’s of quality: Positive Identity, Potency, Purity, and Performance. Explore this infographic to learn more, and visit Quality Supplements to find out what supplements are USP Verified.

Related News

PHARMACY MARKET

Novartis' Sandoz spotlights importance of generic drugs in new social campaign

Novartis | December 17, 2020

Did you realize that 90% of remedies are composed for nonexclusive medications? Novartis' Sandoz is getting the news out about nonexclusive medication with such realities in its as of late dispatched "Request Generics" crusade. It's Sandoz's first significant instruction and mindfulness crusade via online media to advance the estimation of generics. The intended interest group is key partners—patients, clinicians, policymakers and payers—with messages running on LinkedIn and Twitter. Sandoz plans to run the mission through the finish of the principal quarter, perhaps more, contingent upon results. It's as of now chipping away at a second stage that will move center to biosimilar adaptations of marked biologic medications. "Generics are assuming a truly significant job, and I believe it's ideal planning currently to discuss the significant job generics play in a well-working medical care framework," said Carol Lynch, Sandoz's U.S. president and head of North America. Other than featuring the pervasiveness of generics, the online media posts promote their reasonableness and their status as firmly directed items—as protected and powerful as their image name partners. The moderateness and security messages are significant, alongside the general token of the opposition generics give in the commercial center. The duplicates of costlier marked medications help to make "a sound serious market that is directed to patients having expanded admittance to the prescriptions they need," Lynch said. Nonexclusive medications saved the U.S. medical services framework $313 billion a year ago, as per the 2020 yearly report of conventional and biosimilar access and reserve funds in the U.S. from the Association for Accessible Medicines, a generics industry exchange gathering.

Read More

Upadhye Cwik LLP Guides About Innovative Legal Practices On Pharmaceutical and FDA Issues in COVID-19 World

Upadhye Cwik LLP | July 02, 2020

The COVID-19 pandemic continues to turn the world upside down. And when upside down, the legal issues surrounding pharmaceuticals and the FDA become apparent. We identify a few areas that our law firm is working on for clients. Our patent work remains busy helping clients with rationalizing patent portfolios, conducting infringement-mapping exercises to find potential licensing revenues, and patent litigation to enforce patent rights. Interestingly we see some clients not cutting the pipeline and thus increasing their patent activities to be ready with new products once the economy returns. Other companies are using the 505(b)(2) platform to come up with new products in less costly ways. The COVID-19 crisis has caused a serious disruption on contracts, from supplying raw materials to end producers, up to the inability to pay for product received due to cash-flow problems. We are seeing clients invoking the Force Majeure clause to get out of contracts and similarly helping clients to force the other party to stay in the contract. The failure to supply may also cause consequential problems such as stock-out penalties, product recalls, or mitigation. We are also drafting new contracts to account for pandemics and other viral/bacterial outbreaks. Nevertheless, business is business and we are helping clients in commercial litigation in order to enforce contracts. Other clients are using commercial litigation to protect market share.

Read More

CSA Medical Announces First Procedure in the SPRAY-CB Pivotal Trial for the Treatment of Chronic Bronchitis

CSA Medical Inc | October 22, 2020

CSA Medical Inc., a developer of medical devices advancing the power of liquid nitrogen spray cryotherapy, today announced the first patient treated in the SPRAY-CB, U.S. pivotal trial utilizing the RejuvenAir® System for COPD with Chronic Bronchitis at Temple University. Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University (LKSOM) and Director of the Temple Lung Center, and principal investigator completed the procedure on October 14th. "We are pleased to have performed the first procedure in this landmark pivotal trial, building on the European data in which patients achieved meaningful improvements in their cough and overall quality of life," said Dr. Criner. "RejuvenAir Metered Cryospray is a promising new interventional tool that has the potential to reduce emergency hospital visits due to chronic bronchitis symptoms. This definitive intervention may provide a long-term benefit to millions of adults suffering with Chronic Bronchitis."

Read More

Spotlight

There’s a good chance your diet leaves you nutritionally deficient. You may take (or may be thinking about taking) a supplement to make up the deficiency. Dietary supplements are not regulated the same way drugs are regulated, so it’s important to know what you’ll be buying before you head to the store. USP Verified Dietary Supplements are rigorously tested and audited using the four P’s of quality: Positive Identity, Potency, Purity, and Performance. Explore this infographic to learn more, and visit Quality Supplements to find out what supplements are USP Verified.